Preoperative chemotherapy and radiation therapy for patients with cancer of the esophagus: a potentially curative approach.

Authors:
  • LLL Leichman
    L Leichman
  • ZSZ Steiger
    Z Steiger
  • HSH G Seydel
    H G Seydel
  • ADA Dindogru
    A Dindogru
  • JKJ Kinzie
    J Kinzie
  • STS Toben
    S Toben
  • GMG MacKenzie
    G MacKenzie
  • JSJ Shell
    J Shell
Publisher website
Google Scholar
Abstract
Twenty-one patients with squamous cell cancer of the esophagus were entered into a pilot clinical trial using preoperative chemotherapy (5-fluorouracil and cis-platinum) and radiation with the intent of improving cure rate and survival. After the preoperative treatment was complete, 15 patients (71%) were resected for cure. Seven (47%) of 15 had no histologic evidence of cancer in the resected esophagus, but two of these had microscopic cancer in resected lymph nodes. The median survival for all patients entered in the trial was 18 months, whereas for those with no cancer in the resected esophagus the median survival was 24 months. The six patients who either refused surgery (two patients) or were unresectable at surgery (four patients) died within nine months. Our conclusion in this trial is that survival and potential cure are clearly linked to successfully clearing the esophagus and nodes of histologic evidence of tumor through preoperative treatment.